Cracking the Case in Rare Disorders with Respiratory Symptoms: Practical Approaches to Identification and Clinical Management

CME: 1.5

October 25, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in unusual disorders caused by hypereosinophilia. Eosinophilic disorders are a broad range of conditions with extremely varied pathophysiologies and clinical presentations. They can range from asymptomatic or mild to severe and fatal, making this a complex and difficult medical area. They are defined by organ dysfunction induced by activated eosinophils that affect 1 or more organs and by varying degrees of increased eosinophil numbers in the blood. Eosinophilic disorders encompass allergic diseases (eg, eosinophilic asthma), autoimmune diseases (eg, eosinophil granulomatosis with polyangiitis (EGPA)) and hypereosinophilic syndrome (HES). Novel therapies targeting IL5, IL4, IL13, and immunoglobulin E are now being investigated.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Analyze the underlying pathogenesis of eosinophilic disorders
  • Develop a differential diagnosis for management of patients with eosinophilic disorders
  • Apply efficacy and safety data for emerging therapies for patients with eosinophilic disorders
  • Implement evidence-based guidelines in managing patients with eosinophilic disorders

Post a comment to this article